Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

1,231 public trials 93 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

NCT00706849

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +17 more
Locations
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • Mission Viejo, California, United States
  • Newport Beach, California, United States
View all 48 locations
View Trial Details
Completed

Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis

NCT00794664

Conditions
Cardiovascular Diseases, Coronary Disease, Coronary Heart Disease, +9 more
Locations
  • Jupiter, Florida, United States
  • Winter Park, Florida, United States
  • Atlanta, Georgia, United States
  • Kansas City, Kansas, United States
View all 27 locations
View Trial Details
Completed

Leptin to Treat Lipodystrophy

NCT00025883

Conditions
Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +12 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia

NCT02250105

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations
  • Orange County Research Center Tustin, California, United States
  • Louisville Metabolic and Atherosclerosis Research Center Louisville, Kentucky, United States
  • Maine Research Associates Auburn, Maine, United States
  • Sterling Clinical Research Inc Cincinnati, Ohio, United States
View Trial Details
Completed

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)

NCT01644188

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number 840980 Birmingham, Alabama, United States
  • Investigational Site Number 840918 Phoenix, Arizona, United States
  • Investigational Site Number 840925 Tucson, Arizona, United States
  • Investigational Site Number 840959 Anaheim, California, United States
View all 126 locations
View Trial Details

Related conditions